Land: Storbritannia
Språk: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Dipyridamole
Boehringer Ingelheim Ltd
B01AC07
Dipyridamole
100mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02090000; GTIN: 5012816070318
PERSANTIN 100MG TABLETS (dipyridamole) PATIENT INFORMATION LEAFLET READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE * Keep this leaflet. You may need to read it again. * If you have any further questions, ask your doctor or pharmacist * This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. * If any of the side effects gets troublesome or serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Your medicine is called Persantin 100mg Tablets, but will be reffered to as Persantin Tablets throughout this leaflet. IN THIS LEAFLET: What Persantin Tablets are and what they are used for Before you take Persantin Tablets How to take Persantin Tablets Possible side effects How to store Persantin Tablets Further information WHAT PERSANTIN TABLETS ARE AND WHAT THEY ARE USED FOR The name of your medicine is Persantin Tablets. It contains a medicine called Dipyridamole. This belongs to a group of medicines called ‘anti-thrombotic agents’, which are used to help stop blood clots forming. Persantin Tablets help stop blood clots which may occur if you have had your heart valves replaced. BEFORE YOU TAKE PERSANTIN TABLETS DO NOT TAKE PERSANTIN TABLETS IF YOU ARE ALLERGIC (HYPERSENSITIVE) TO: * Dipyridamole Any of the other ingredients of Persantin Tablets (see section 6: Further information) TAKE SPECIAL CARE WITH PERSANTIN TABLETS Check with your doctor or pharmacist before taking your medicine if: * You have angina or other heart problems (including heart valve or circulation problems) or have had a recent heart attack * You have myasthenia gravis (a rare muscle problem) * You have any bleeding problems * You are pregnant or planning to become pregnant or are breast-feeding * You have been told by your doctor that you have an intolerance to some sugars If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Persantin Table Les hele dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT PERSANTIN Tablets 100 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Dipyridamole 100 mg. For excipients, see 6.1. 3. PHARMACEUTICAL FORM Coated Tablets. Round, white, biconvex, shiny, sugar-coated tablets. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS An adjunct to oral anti-coagulation for prophylaxis of thrombo-embolism associated with prosthetic heart valves. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION _Adults: _ 300-600 mg daily in three or four doses. _Children: _ PERSANTIN is not recommended for children. PERSANTIN should usually be taken before meals. 4.3 CONTRAINDICATIONS Hypersensitivity to any of the components of the product. In case of rare hereditary conditions that may be incompatible with an excipient of the product (please refer to Special warnings and precautions for use) the use of the product is contraindicated. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Among other properties, dipyridamole acts as a vasodilator. It should be used with caution in patients with severe coronary artery disease, including unstable angina and/or recent myocardial infarction, left ventricular outflow obstruction or haemodynamic instability (e.g. decompensated heart failure). Patients being treated with regular oral doses of PERSANTIN should not receive additional intravenous dipyridamole. Clinical experience suggests that patients being treated with oral dipyridamole who also require pharmacological stress testing with intravenous dipyridamole, should discontinue drugs containing oral dipyridamole for twenty-four hours prior to stress testing. In patients with myasthenia gravis, readjustment of therapy may be necessary after changes in dipyridamole dosage (see Drug Interactions). PERSANTIN should be used with caution in patients with coagulation disorders. A small number of cases have been reported in which unconjugated dipyridamole was shown to be incorporated into gallstones to a variable extent (upto 70% by dry weight of stone). These pati Les hele dokumentet